Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclosporin for Steroid-Resistant Leprosy Type 1 Reactions
NCT00919451Phase 2Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Aug 2010
- Primary completion
- Jun 2013
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of cyclosporine in leprosy (HD), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Improvement in nerve function at 32 weeks. Started Aug 2010; status: completed.
02
Drugs
cyclosporine
03
Conditions
leprosy (HD)
Beyond the preview
Go deeper on NCT00919451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00919451.